International Peer-Reviewed JournalOpen AccessISSN 2456-8880
irejournals@gmail.com+91-7433024337

Home / Current Issue / Paper 1719870

1719870 Vol 10 · Issue 1 Download Paper

Managing Multimorbidity in Internal Medicine: A Framework for Saudi Healthcare System Efficiency

Ziaur Rahman

Subject area: Science,Engineering and Technology  ·  Area of research: Multimorbidity in Internal Medicine

DOI: https://doi.org/10.64388/IREV10I1-1719870

Abstract

Multimorbidity is now a central test of internal medicine performance because patients rarely arrive with a single, guideline-contained disease. In Saudi Arabia, longer life expectancy, diabetes, cardiovascular disease, obesity, respiratory disease, cancer survivorship and mental health need are converging with Vision 2030 reforms that emphasise prevention, digital transformation and accountable value. This review develops a practical framework for managing multimorbidity in internal medicine to improve Saudi healthcare system efficiency. A narrative review methodology was used, prioritising peer-reviewed literature and policy evidence published from 2020 to 2025 on multimorbidity, integrated care, chronic disease management, Saudi health transformation, primary care redesign, digital health, medication optimisation and value-based healthcare. The paper proposes a five-part framework: population risk stratification, shared goal-oriented care planning, internal medicine coordination hubs, digital continuity, and outcomes-based governance. The model is intended to reduce fragmentation, duplicate testing, preventable admission, adverse drug events and delayed escalation while preserving person-centred decision-making. The review argues that Saudi internal medicine departments can become coordination engines between primary care, subspecialties, emergency departments and community services. Efficiency should therefore be measured not only by throughput, but by continuity, avoidable utilisation, patient-reported outcomes, medication safety, equity and clinician workload. Implementation requires interoperable records, clinical pharmacy, nurse coordination, mental health integration, telemedicine, home monitoring, and cluster-level dashboards aligned with the Health Sector Transformation Program. The framework offers an adaptable roadmap for hospitals and health clusters seeking Scopus-level evidence translation into operational improvement.

Keywords

Multimorbidity, Internal Medicine, Saudi Arabia, Vision 2030, Chronic Diseases, Integrated Care, Health System Efficiency, Digital Health.

References

[1] Academy of Medical Sciences. (2020). Multimorbidity: A priority for global health research. London: Academy of Medical Sciences.

[2] Alasiri, A. A., & Mohammed, V. (2022). Healthcare transformation in Saudi Arabia: An overview since the launch of Vision 2030. Health Services Insights, 15, 1-7.

[3] Alharbi, M. S., Alshammari, T., & Alessa, T. (2025). Healthcare transformation through population health management implementation in a Saudi health cluster. BMC Health Services Research, 25, 1-12.

[4] Alnuwaysir, N., Alqahtani, F., & Alshahrani, M. (2025). Review of multimorbidity in Saudi Arabia: Prevalence, gender differences and common chronic diseases. Journal of Multimorbidity and Comorbidity, 15, 1-12.

[5] Alqadasi, E. T., Alghamdi, S., & Al-Zalabani, A. (2024). Burden of non-communicable diseases in Health Council of Gulf Cooperation countries. BMC Public Health, 24, 1-13.

[6] Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2020). Epidemiology of multimorbidity and implications for health care, research and medical education. Updated clinical synthesis. The Lancet Regional Health, 1, 100-112.

[7] Chowdhury, S., Mok, D., & Leenen, L. (2021). Transformation of health care and the new model of care in Saudi Arabia: Kingdom's Vision 2030. Journal of Medicine and Life, 14(3), 347-354.

[8] GBD 2019 Saudi Arabia Collaborators. (2020). The burden of disease in Saudi Arabia 1990-2017: Results from the Global Burden of Disease Study. The Lancet Planetary Health, 4(5), e195-e208.

[9] Greenhalgh, T., Thorne, S., & Malterud, K. (2020). Time to challenge the spurious hierarchy of systematic over narrative reviews. European Journal of Clinical Investigation, 48(6), e12931.

[10] Haleem, A., Javaid, M., Singh, R. P., & Suman, R. (2021). Telemedicine for healthcare: Capabilities, features, barriers and applications. Sensors International, 2, 100117.

[11] Hazazi, A., Chandramohan, S., & AlBuhairan, F. (2022). Noncommunicable diseases and health system responses in Saudi Arabia: Focus on policies and strategies. International Journal of Environmental Research and Public Health, 19(4), 1-15.

[12] Health Sector Transformation Program. (2023). Health Sector Transformation Program delivery plan and strategic priorities. Riyadh: Saudi Vision 2030.

[13] Ho, I. S. S., Azcoaga-Lorenzo, A., Akbari, A., Davies, J., Hodgins, P., & Khunti, K. (2022). Measuring multimorbidity in research: Delphi consensus study. BMJ Medicine, 1(1), e000247.

[14] Khezrian, M., McNeil, C. J., Murray, A. D., & Myint, P. K. (2020). An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeutic Advances in Drug Safety, 11, 1-10.

[15] Kuipers, S. J., Nieboer, A. P., & Cramm, J. M. (2021). Views of patients with multi-morbidity on what is important for patient-centered care in the primary care setting. BMC Family Practice, 22, 1-12.

[16] Mair, F. S., & May, C. R. (2021). Thinking about the burden of treatment. BMJ, 372, n151.

[17] Muth, C., Blom, J. W., Smith, S. M., Johnell, K., Gonzalez-Gonzalez, A. I., Nguyen, T. S., & Brueckle, M. S. (2021). Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy. Journal of Internal Medicine, 290(2), 261-275.

[18] OECD. (2023). Ready for the Next Crisis? Investing in Health System Resilience. Paris: OECD Publishing.

[19] Porter, M. E., Teisberg, E. O., & Wallace, S. (2021). Redefining health care delivery around value and outcomes. NEJM Catalyst, 2(3), 1-10.

[20] Rankin, A., Cadogan, C. A., Patterson, S. M., Kerse, N., Cardwell, C. R., Bradley, M. C., & Ryan, C. (2021). Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database of Systematic Reviews, 9, CD008165.

[21] Salisbury, C., Man, M. S., Bower, P., Guthrie, B., Chaplin, K., Gaunt, D. M., & Mercer, S. W. (2021). Management of multimorbidity using a patient-centred care model: A pragmatic trial. The Lancet, 398, 41-50.

[22] Seakamela, K. P., Shipalana, N., & Mash, R. (2025). Multimorbidity management: A scoping review of interventions and implementation approaches. BMC Primary Care, 26, 1-15.

[23] Skou, S. T., Mair, F. S., Fortin, M., Guthrie, B., Nunes, B. P., Miranda, J. J., & Smith, S. M. (2022). Multimorbidity. Nature Reviews Disease Primers, 8, 48.

[24] Suleiman, A. K., Almutairi, A., & Alotaibi, N. (2025). Transforming healthcare in Saudi Arabia under Vision 2030: Progress, opportunities and challenges. Healthcare, 13(1), 1-17.

[25] Sutton, R. T., Pincock, D., Baumgart, D. C., Sadowski, D. C., Fedorak, R. N., & Kroeker, K. I. (2020). An overview of clinical decision support systems: Benefits, risks and strategies. NPJ Digital Medicine, 3, 17.

[26] Tran, V. T., Barnes, C., Montori, V. M., Falissard, B., & Ravaud, P. (2020). Taxonomy of the burden of treatment: A multi-country web-based qualitative study. BMC Medicine, 18, 115.

[27] WHO. (2021). Global Patient Safety Action Plan 2021-2030: Towards eliminating avoidable harm in health care. Geneva: World Health Organization.

[28] World Health Organization. (2022). Noncommunicable diseases country profiles and health-system response guidance. Geneva: WHO.

[29] Xu, X., Mishra, G. D., & Jones, M. (2023). Evidence on multimorbidity from definition to intervention: An overview of systematic reviews. Ageing Research Reviews, 89, 101987.

[30] Zhang, Y., Wodchis, W. P., & Mattison, C. A. (2025). Can integrated care interventions strengthen primary care and improve outcomes for people with multimorbidity? Health Research Policy and Systems, 23, 1-16.

How to cite this paper

Ziaur Rahman "Managing Multimorbidity in Internal Medicine: A Framework for Saudi Healthcare System Efficiency" Iconic Research And Engineering Journals Volume 10 Issue 1 2026 Page 1721-1732 https://doi.org/10.64388/IREV10I1-1719870
Ziaur Rahman "Managing Multimorbidity in Internal Medicine: A Framework for Saudi Healthcare System Efficiency" Iconic Research And Engineering Journals, vol. 10, no. 1, Jul. 2026, doi: https://doi.org/10.64388/IREV10I1-1719870
Ziaur Rahman (2026). Managing Multimorbidity in Internal Medicine: A Framework for Saudi Healthcare System Efficiency. Iconic Research And Engineering Journals, 10(1). doi: https://doi.org/10.64388/IREV10I1-1719870
Ziaur Rahman "Managing Multimorbidity in Internal Medicine: A Framework for Saudi Healthcare System Efficiency" Iconic Research And Engineering Journals, vol. 10, no. 1, Jul. 2026. Crossref, https://doi.org/10.64388/IREV10I1-1719870
@article{1719870,
      author = {Ziaur Rahman},
      title = {Managing Multimorbidity in Internal Medicine: A Framework for Saudi Healthcare System Efficiency},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {10},
      number = {1},
      pages = {1721-1732},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1719870.pdf},
      abstract = {Multimorbidity is now a central test of internal medicine performance because patients rarely arrive with a single, guideline-contained disease. In Saudi Arabia, longer life expectancy, diabetes, cardiovascular disease, obesity, respiratory disease, cancer survivorship and mental health need are converging with Vision 2030 reforms that emphasise prevention, digital transformation and accountable value. This review develops a practical framework for managing multimorbidity in internal medicine to improve Saudi healthcare system efficiency. A narrative review methodology was used, prioritising peer-reviewed literature and policy evidence published from 2020 to 2025 on multimorbidity, integrated care, chronic disease management, Saudi health transformation, primary care redesign, digital health, medication optimisation and value-based healthcare. The paper proposes a five-part framework: population risk stratification, shared goal-oriented care planning, internal medicine coordination hubs, digital continuity, and outcomes-based governance. The model is intended to reduce fragmentation, duplicate testing, preventable admission, adverse drug events and delayed escalation while preserving person-centred decision-making. The review argues that Saudi internal medicine departments can become coordination engines between primary care, subspecialties, emergency departments and community services. Efficiency should therefore be measured not only by throughput, but by continuity, avoidable utilisation, patient-reported outcomes, medication safety, equity and clinician workload. Implementation requires interoperable records, clinical pharmacy, nurse coordination, mental health integration, telemedicine, home monitoring, and cluster-level dashboards aligned with the Health Sector Transformation Program. The framework offers an adaptable roadmap for hospitals and health clusters seeking Scopus-level evidence translation into operational improvement.},
      keywords = {Multimorbidity, Internal Medicine, Saudi Arabia, Vision 2030, Chronic Diseases, Integrated Care, Health System Efficiency, Digital Health.},
      month = {July},
      doi = {https://doi.org/10.64388/IREV10I1-1719870}
  }